DrugId:  1
1. Name:  AZX-100
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in scar tissue.
DrugId:  2
1. Name:  Chili pepper
2. Groups:  Approved
3. Description:  Chili pepper allergenic extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  3
1. Name:  AG-702
2. Groups:  Investigational
3. Description:  AG-702 is a recombinant human heat shock protein also known as stress protein. It is also known as HSPs, which are a group of proteins that are induced when a cell undergoes various types of environmental stresses like heat, cold and oxygen deprivation. HSPs are present in all cells in all life forms from bacteria to mammals, and their structure and function are similar across these diverse life forms. This drug is developed by antigenics for the treatment of genital herpes infection and is under phase I of clinical trial.
4. Indication:  Investigated for use/treatment in genital herpes.
DrugId:  4
1. Name:  Capsaicin
2. Groups:  Approved
3. Description:  Capsaicin is most often used as a topical analgesic and exists in many formulations of cream, liquid, and patch preparations of various strengths; however, it may also be found in some dietary supplements. Capsaicin is a naturally-occurring botanical irritant in chili peppers, synthetically derived for pharmaceutical formulations. The most recent capsaicin FDA approval was Qutenza, an 8% capsaicin patch dermal-delivery system, indicated for neuropathic pain associated with post-herpetic neuralgia.
4. Indication:  The capsaicin 8% patch is indicated in the treatment of neuropathic pain associated with post-herpetic neuralgia. There are multiple topical capsaicin formulations available, including creams and solutions, indicated for temporary analgesia in muscle and join pain as well as neuropathic pain. 
DrugId:  5
1. Name:  1,3-Butanediol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  6
1. Name:  Thiodigalactoside
2. Groups:  Experimental
3. Description:  Thiodigalactoside is a solid. This compound belongs to the dihexoses. These are disaccharides containing two hexose carbohydrates. This medication is known to target galectin-1, heat-labile enterotoxin b chain, neurocan core protein, and lactose permease.
4. Indication:  Not Available
DrugId:  7
1. Name:  Haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
2. Groups:  Approved, Investigational
3. Description:  Haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen is an active immunization as a booster dose given intramuscularly to pediatric patients who have received a primary series with a Haemophilus b Conjugate Vaccine that is licensed for primarly immunization. The vaccine contains Haemophilus b capsular polysaccharide (polyribosyl-ribitol-phosphate [PRP]), which is a high molecular weight polymer prepared from the Haemophilus influenzae type b strain 20,752. These are heat inactivated and purified.
4. Indication:  Indicated for active immunization in pediatric patients 15 months through 4 years of age as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b. 
DrugId:  8
1. Name:  Methyl salicylate
2. Groups:  Approved, Vet approved
3. Description:  Methyl salicylate (oil of wintergreen or wintergreen oil) is an organic ester naturally produced by many species of plants, particularly wintergreens. The compound was first extracted and isolated from plant species Gaultheria procumbens in 1843. It is also synthetically produced, used as a fragrance, in foods and beverages, and in liniments. It forms a colorless to yellow or reddish liquid and exhibits a characteristic odor and taste of wintergreen. For acute joint and muscular pain, methyl salicylate is used as a rubefacient and analgesic in deep heating liniments. It is used as a flavoring agent in chewing gums and mints in small concentrations and added as antiseptic in mouthwash solutions.
4. Indication:  Ointments or liniments containing methyl salicylate are applied topically as counter irritant for relief of acute pain associated with lumbago,sciatica and rheumatic conditions. Local analgesics for human and veterinary medicine.
DrugId:  9
1. Name:  Tanespimycin
2. Groups:  Investigational
3. Description:  Tanespimycin, manufactured by Conforma Therapeutics is under development as a small molecule inhibitor of heat shock protein 90 (HSP90). It is developed for the treatment of several types of cancer, solid tumors or chronic myelogenous leukemia.
4. Indication:  Investigated for use/treatment in leukemia (myeloid) and solid tumors.
DrugId:  10
1. Name:  Glutaral
2. Groups:  Experimental
3. Description:  One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.
4. Indication:  Not Available
DrugId:  11
1. Name:  Geldanamycin
2. Groups:  Experimental, Investigational
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  12
1. Name:  Tea tree oil
2. Groups:  Approved
3. Description:  Tea tree oil is also referred to as melaleuca oil due to its origin from Melaleuca alternifolia, a tea tree native to Australia. The oil is extracted from the leaves via distillation. It has been used in traditional medicine due to its antiseptic properties, however the mechanism of action of tea tree oil is unclear. Oral ingestion of tea tree oil is toxic, so it is topically applied for skin conditions such as fungal infections, acne, lice, scabies, athlete's foot (tinea pedis) and dandruff. It is also found in cosmetics and skin products to reduce skin blemishes.
4. Indication:  Not Available
DrugId:  13
1. Name:  AUY922
2. Groups:  Investigational
3. Description:  AUY922 has been used in trials studying the treatment of Lymphoma, Breast Cancer, Metastatic Disease, Advanced Solid Tumors, and Hematologic Neoplasms, among others.
4. Indication:  Not Available
DrugId:  14
1. Name:  XL-888
2. Groups:  Investigational
3. Description:  XL888 has been used in trials studying the treatment of Cancer and Melanoma.
4. Indication:  Not Available
DrugId:  15
1. Name:  BIIB021
2. Groups:  Investigational
3. Description:  BIIB021 has been investigated for the treatment of Tumors and Lymphoma.
4. Indication:  Not Available
DrugId:  16
1. Name:  Nitrogen
2. Groups:  Approved, Vet approved
3. Description:  Nitrogen is a chemical element with symbol N and atomic number 7. At room temperature, it is a transparent, odorless diatomic gas.Liquid nitrogen is used principally in cryotherapy for removal of diseased skin. Liquid nitrogen helps in removal of skin lesions through necrosis, which results from the freezing and thawing of cells. Cryotherapy usually done in doctors' office. Also, nitrogen is very famous component in fertilizers and energy-stores.
4. Indication:  Liquid nitrogen is used mainly as a cryogenic agent for the treatment of various benign and malignant skin lesions. 
DrugId:  17
1. Name:  HspE7
2. Groups:  Investigational
3. Description:  HspE7 is a recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from Mycobacterium bovis, and the human papilloma viral (HPV) protein E7. Hsp65, similar to other members of its family of proteins, elicits a strong immune response and may be used to design vaccines against a number of different cancers. E7 protein is involved in carcinogenesis of anal and cervical tumors, and represents a tumor antigen that may be specifically targeted by lymphocytes. It is being developed by StressGen Biotechnologies Corp.
4. Indication:  Investigated for use/treatment in anal dysplasia, cervical dysplasia/cancer, genital warts, HIV infection, infectious and parasitic disease (unspecified), pediatric indications, warts, and viral infection.
DrugId:  18
1. Name:  Lofexidine
2. Groups:  Approved, Investigational
3. Description:  Lofexidine is an alpha2-adrenergic receptor agonist. It can be used as a short acting anti-hypertensive, but is mostly used to help relieve symptoms of heroin or opiate withdrawal in opiate dependency. It is approved in the United Kingdom, but is still undergoing clinical trials in the United States.
4. Indication:  Investigated for use/treatment in addictions and substance abuse.
DrugId:  19
1. Name:  AG-858
2. Groups:  Investigational
3. Description:  AG-858 (autologous heat-shock protein 70 peptide vaccine) isa recombinant cancer vaccine made with tumor-derived heat shock protein 70 (HSP70) peptide complexes. HSP70 associates with antigenic peptides, transporting them into antigen presenting cells (APC) for processing. Tumor-derived HSP70-peptide complexes used in vaccine preparations have been shown to prime tumor immunity and tumor-specific T cells in animal models.
4. Indication:  Investigated for use/treatment in leukemia (myeloid).
DrugId:  20
1. Name:  Vitespen
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in kidney cancer, melanoma, renal cell carcinoma, lymphoma (unspecified), colorectal cancer, and brain cancer.
DrugId:  21
1. Name:  Elesclomol
2. Groups:  Investigational
3. Description:  Elesclomol is a novel, injectable, drug candidate that kills cancer cells by elevating oxidative stress levels beyond a breaking point, triggering programmed cell death. In preclinical models elesclomol showed potent killing of a broad range of cancer cell types at high doses, and an ability to strongly enhance the efficacy of certain chemotherapy agents, with minimal additional toxicity, at moderate doses. It is being developed by Synta Pharmaceuticals.
4. Indication:  Investigated for use/treatment in melanoma.
DrugId:  22
1. Name:  Tannic acid
2. Groups:  Approved
3. Description:  Tannic acid is a polyphenolic compound. It is a type of the commercially available tannins. It acts as a weak acid. Tannic acid is found in the nutgalls formed by insects on twigs of certain oak trees (Quercus infectoria and other Quercus species). It is removed and used as medicine. In the old days it was used as antidote against different poisons.Nowadays, tannic acid is applied topically for the treatment of cold sores, diaper rash, fever blisters and poison ivy. Tannic acid is also taken by mouth and applied directly for bleeding, chronic diarrhea, dysentery, bloody urine, painful joints, persistent coughs, and cancer.
4. Indication:  Tannic acid is indicated for cold sores, fever blisters, diaper rash, minor burn or sunburn and prickly heat.Vaginally, tannic acid is used as a douche for leukorrhea. It has been also indicated for sore throat, inflamed tonsils, spongy or receding gums, and acute dermatitis.
DrugId:  23
1. Name:  Retaspimycin
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in gastric cancer, lung cancer, and multiple myeloma.
DrugId:  24
1. Name:  Doconexent
2. Groups:  Approved, Investigational
3. Description:  A mixture of fish oil and primrose oil, doconexent is used as a high-docosahexaenoic acid (DHA) supplement. DHA is a 22 carbon chain with 6 cis double bonds with anti-inflammatory effects. It can be biosythesized from alpha-linolenic acid or commercially manufactured from microalgae. It is an omega-3 fatty acid and primary structural component of the human brain, cerebral cortex, skin, and retina thus plays an important role in their development and function. The amino-phospholipid DHA is found at a high concentration across several brain subcellular fractions, including nerve terminals, microsomes, synaptic vesicles, and synaptosomal plasma membranes [10].
4. Indication:  Used as a high-docosahexaenoic acid (DHA) oral supplement. 
DrugId:  25
1. Name:  Alvespimycin
2. Groups:  Investigational
3. Description:  Alvespimycin is a derivative of geldanamycin and heat shock protein (HSP) 90 inhibitor. It has been used in trials studying the treatment of solid tumor in various cancer as an antitumor agent. In comparison to the first HSP90 inhibitor tanespimycin, it exhibits some pharmacologically desirable properties such as reduced metabolic liability, lower plasma protein binding, increased water solubility, higher oral bioavailability, reduced hepatotoxicity and superior antitumor activity [1].
4. Indication:  Investigated for use as an antineoplastic agent for solid tumors, advanced solid tumours or acute myeloid leukaemia. 
